Premenstrual Syndrome Treatment Market 2028 By Product, Type, Distribution Channel, and Geography | The Insight Partners

    Premenstrual Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Analgesics, Antidepressants, Oral Contraceptives and Ovarian Suppression Agents, Others); Type (Prescription, OTC); Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy, Online Providers), and Geography

    Report Code: TIPRE00013510 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION

    Premenstrual syndrome (PMS) shows a broader range of symptoms, such as mood swings, food cravings, fatigue, irritability, depression, and tender breasts. It is commonly seen among three of every four menstruating women and experienced some form of premenstrual syndrome. It is caused due to cyclic changes in hormones, changes in neurotransmitters, and depression. It can be treated by medication, altering lifestyles, and habits.

    MARKET DYNAMICS

    The market for the premenstrual syndrome treatment market is anticipated to grow due to key factors such as increasing incidences premenstrual syndrome due to changing lifestyles, irregular schedules that lead stress, and growing development in the pharmaceutical industry. The market is likely to have good growth opportunities due to rising awareness about the treatment and growing support from governments for women's welfare.

    MARKET SCOPE

    The "Premenstrual Syndrome Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of premenstrual syndrome treatment market with detailed market segmentation by product, type, and distribution channel. The premenstrual syndrome treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in premenstrual syndrome treatment market and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The premenstrual syndrome treatment market is segmented on the basis of product, type, and distribution channel. On the basis of product, the market is classified as analgesics, antidepressants, oral contraceptives and ovarian suppression agents, and others. Based on type, the market is segmented as prescription, and OTC. And based on distribution channel, the market is divided as hospital pharmacy, drug store and retail pharmacy, and online providers.

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the premenstrual syndrome treatment market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The premenstrual syndrome treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting premenstrual syndrome treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Premenstrual syndrome treatment market in these regions.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the premenstrual syndrome treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Premenstrual syndrome treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Premenstrual syndrome treatment in the global market. Below mentioned is the list of few companies engaged in the Premenstrual syndrome treatment market.

    The report also includes the profiles of key players in premenstrual syndrome treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    •  ABBVIE INC.
    •  AstraZeneca plc.
    •  BASF Corporation
    •  Bayer AG
    •  Dr. Reddy's Laboratories Ltd
    •  Eli Lilly And Company
    •  GlaxoSmithKline Plc.
    •  H. Lundbeck A/S
    •  Pfizer Inc.
    •  Shionogi Inc.

    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Premenstrual Syndrome Treatment Market - By Product
    1.3.2 Premenstrual Syndrome Treatment Market - By Type
    1.3.3 Premenstrual Syndrome Treatment Market - By Distribution Channel
    1.3.4 Premenstrual Syndrome Treatment Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. PREMENSTRUAL SYNDROME TREATMENT MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. PREMENSTRUAL SYNDROME TREATMENT MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. PREMENSTRUAL SYNDROME TREATMENT MARKET - GLOBAL MARKET ANALYSIS
    6.1. PREMENSTRUAL SYNDROME TREATMENT - GLOBAL MARKET OVERVIEW
    6.2. PREMENSTRUAL SYNDROME TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. ANALGESICS
    7.3.1. Overview
    7.3.2. Analgesics Market Forecast and Analysis
    7.4. ANTIDEPRESSANTS
    7.4.1. Overview
    7.4.2. Antidepressants Market Forecast and Analysis
    7.5. ORAL CONTRACEPTIVES AND OVARIAN SUPPRESSION AGENTS
    7.5.1. Overview
    7.5.2. Oral Contraceptives and Ovarian Suppression Agents Market Forecast and Analysis
    7.6. OTHERS
    7.6.1. Overview
    7.6.2. Others Market Forecast and Analysis
    8. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    8.1. OVERVIEW
    8.2. TYPE MARKET FORECASTS AND ANALYSIS
    8.3. PRESCRIPTION
    8.3.1. Overview
    8.3.2. Prescription Market Forecast and Analysis
    8.4. OTC
    8.4.1. Overview
    8.4.2. OTC Market Forecast and Analysis
    9. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    9.1. OVERVIEW
    9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL PHARMACY
    9.3.1. Overview
    9.3.2. Hospital Pharmacy Market Forecast and Analysis
    9.4. DRUG STORE AND RETAIL PHARMACY
    9.4.1. Overview
    9.4.2. Drug Store and Retail Pharmacy Market Forecast and Analysis
    9.5. ONLINE PROVIDERS
    9.5.1. Overview
    9.5.2. Online Providers Market Forecast and Analysis
    10. PREMENSTRUAL SYNDROME TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Premenstrual Syndrome Treatment Market Overview
    10.1.2 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis
    10.1.3 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
    10.1.4 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
    10.1.5 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
    10.1.6 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Premenstrual Syndrome Treatment Market
    10.1.6.1.1 United States Premenstrual Syndrome Treatment Market by Product
    10.1.6.1.2 United States Premenstrual Syndrome Treatment Market by Type
    10.1.6.1.3 United States Premenstrual Syndrome Treatment Market by Distribution Channel
    10.1.6.2 Canada Premenstrual Syndrome Treatment Market
    10.1.6.2.1 Canada Premenstrual Syndrome Treatment Market by Product
    10.1.6.2.2 Canada Premenstrual Syndrome Treatment Market by Type
    10.1.6.2.3 Canada Premenstrual Syndrome Treatment Market by Distribution Channel
    10.1.6.3 Mexico Premenstrual Syndrome Treatment Market
    10.1.6.3.1 Mexico Premenstrual Syndrome Treatment Market by Product
    10.1.6.3.2 Mexico Premenstrual Syndrome Treatment Market by Type
    10.1.6.3.3 Mexico Premenstrual Syndrome Treatment Market by Distribution Channel
    10.2. EUROPE
    10.2.1 Europe Premenstrual Syndrome Treatment Market Overview
    10.2.2 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis
    10.2.3 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
    10.2.4 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
    10.2.5 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
    10.2.6 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Premenstrual Syndrome Treatment Market
    10.2.6.1.1 Germany Premenstrual Syndrome Treatment Market by Product
    10.2.6.1.2 Germany Premenstrual Syndrome Treatment Market by Type
    10.2.6.1.3 Germany Premenstrual Syndrome Treatment Market by Distribution Channel
    10.2.6.2 France Premenstrual Syndrome Treatment Market
    10.2.6.2.1 France Premenstrual Syndrome Treatment Market by Product
    10.2.6.2.2 France Premenstrual Syndrome Treatment Market by Type
    10.2.6.2.3 France Premenstrual Syndrome Treatment Market by Distribution Channel
    10.2.6.3 Italy Premenstrual Syndrome Treatment Market
    10.2.6.3.1 Italy Premenstrual Syndrome Treatment Market by Product
    10.2.6.3.2 Italy Premenstrual Syndrome Treatment Market by Type
    10.2.6.3.3 Italy Premenstrual Syndrome Treatment Market by Distribution Channel
    10.2.6.4 Spain Premenstrual Syndrome Treatment Market
    10.2.6.4.1 Spain Premenstrual Syndrome Treatment Market by Product
    10.2.6.4.2 Spain Premenstrual Syndrome Treatment Market by Type
    10.2.6.4.3 Spain Premenstrual Syndrome Treatment Market by Distribution Channel
    10.2.6.5 United Kingdom Premenstrual Syndrome Treatment Market
    10.2.6.5.1 United Kingdom Premenstrual Syndrome Treatment Market by Product
    10.2.6.5.2 United Kingdom Premenstrual Syndrome Treatment Market by Type
    10.2.6.5.3 United Kingdom Premenstrual Syndrome Treatment Market by Distribution Channel
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Premenstrual Syndrome Treatment Market Overview
    10.3.2 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis
    10.3.3 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
    10.3.4 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
    10.3.5 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
    10.3.6 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Premenstrual Syndrome Treatment Market
    10.3.6.1.1 Australia Premenstrual Syndrome Treatment Market by Product
    10.3.6.1.2 Australia Premenstrual Syndrome Treatment Market by Type
    10.3.6.1.3 Australia Premenstrual Syndrome Treatment Market by Distribution Channel
    10.3.6.2 China Premenstrual Syndrome Treatment Market
    10.3.6.2.1 China Premenstrual Syndrome Treatment Market by Product
    10.3.6.2.2 China Premenstrual Syndrome Treatment Market by Type
    10.3.6.2.3 China Premenstrual Syndrome Treatment Market by Distribution Channel
    10.3.6.3 India Premenstrual Syndrome Treatment Market
    10.3.6.3.1 India Premenstrual Syndrome Treatment Market by Product
    10.3.6.3.2 India Premenstrual Syndrome Treatment Market by Type
    10.3.6.3.3 India Premenstrual Syndrome Treatment Market by Distribution Channel
    10.3.6.4 Japan Premenstrual Syndrome Treatment Market
    10.3.6.4.1 Japan Premenstrual Syndrome Treatment Market by Product
    10.3.6.4.2 Japan Premenstrual Syndrome Treatment Market by Type
    10.3.6.4.3 Japan Premenstrual Syndrome Treatment Market by Distribution Channel
    10.3.6.5 South Korea Premenstrual Syndrome Treatment Market
    10.3.6.5.1 South Korea Premenstrual Syndrome Treatment Market by Product
    10.3.6.5.2 South Korea Premenstrual Syndrome Treatment Market by Type
    10.3.6.5.3 South Korea Premenstrual Syndrome Treatment Market by Distribution Channel
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Premenstrual Syndrome Treatment Market Overview
    10.4.2 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis
    10.4.3 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
    10.4.4 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
    10.4.5 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
    10.4.6 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Premenstrual Syndrome Treatment Market
    10.4.6.1.1 South Africa Premenstrual Syndrome Treatment Market by Product
    10.4.6.1.2 South Africa Premenstrual Syndrome Treatment Market by Type
    10.4.6.1.3 South Africa Premenstrual Syndrome Treatment Market by Distribution Channel
    10.4.6.2 Saudi Arabia Premenstrual Syndrome Treatment Market
    10.4.6.2.1 Saudi Arabia Premenstrual Syndrome Treatment Market by Product
    10.4.6.2.2 Saudi Arabia Premenstrual Syndrome Treatment Market by Type
    10.4.6.2.3 Saudi Arabia Premenstrual Syndrome Treatment Market by Distribution Channel
    10.4.6.3 U.A.E Premenstrual Syndrome Treatment Market
    10.4.6.3.1 U.A.E Premenstrual Syndrome Treatment Market by Product
    10.4.6.3.2 U.A.E Premenstrual Syndrome Treatment Market by Type
    10.4.6.3.3 U.A.E Premenstrual Syndrome Treatment Market by Distribution Channel
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Premenstrual Syndrome Treatment Market Overview
    10.5.2 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis
    10.5.3 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
    10.5.4 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
    10.5.5 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
    10.5.6 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Premenstrual Syndrome Treatment Market
    10.5.6.1.1 Brazil Premenstrual Syndrome Treatment Market by Product
    10.5.6.1.2 Brazil Premenstrual Syndrome Treatment Market by Type
    10.5.6.1.3 Brazil Premenstrual Syndrome Treatment Market by Distribution Channel
    10.5.6.2 Argentina Premenstrual Syndrome Treatment Market
    10.5.6.2.1 Argentina Premenstrual Syndrome Treatment Market by Product
    10.5.6.2.2 Argentina Premenstrual Syndrome Treatment Market by Type
    10.5.6.2.3 Argentina Premenstrual Syndrome Treatment Market by Distribution Channel
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Rest of the World
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. PREMENSTRUAL SYNDROME TREATMENT MARKET, KEY COMPANY PROFILES
    13.1. ABBVIE INC.
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. ASTRAZENECA PLC.
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. BASF CORPORATION
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. BAYER AG
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. DR. REDDY'S LABORATORIES LTD
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. ELI LILLY AND COMPANY
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. GLAXOSMITHKLINE PLC.
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. H. LUNDBECK A/S
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. PFIZER INC.
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. SHIONOGI INC.
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    1. ABBVIE INC.
    2. AstraZeneca plc.
    3. BASF Corporation
    4. Bayer AG
    5. Dr. Reddy's Laboratories Ltd
    6. Eli Lilly And Company
    7. GlaxoSmithKline Plc.
    8. H. Lundbeck A/S
    9. Pfizer Inc.
    10. Shionogi Inc.
    TIPRE00013510
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount